Business Context and Reporting Period
This Form 8-K reports on the results of the 2026 Annual Meeting of Stockholders held by vTv Therapeutics Inc. on June 26, 2026. The filing details the outcomes of three specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were voted upon at the Annual Meeting:
- Election of Directors: Seven nominees were elected to the Board of Directors for terms expiring at the 2027 annual meeting. Voting results varied significantly among nominees:
- Fahed Al Marzooqi and Richard S. Nelson received the highest support, with approximately 2.39 million "For" votes each.
- Srinivas Akkaraju, Raymond Cheong, Anne Phillips, Paul Sekhri, and Daniel K. Spiegelman received between 720,000 and 905,000 "For" votes, with "Withheld" votes exceeding "For" votes for these candidates.
- All nominees received 310,535 "Broker Non-Votes."
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- For: 2,964,869
- Against: 1,952
- Abstain: 2,869
- Advisory Vote on Executive Compensation: A nonbinding advisory vote on the compensation of named executive officers was held.
- For: 686,535
- Against: 5,291
- Abstain: 1,967,329
- Broker Non-Votes: 310,535
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items beyond the voting results.
Important Facts for Investors to Verify
- Verify the total number of shares outstanding to calculate the percentage of votes cast "For" versus "Withheld" for the director nominees, as several nominees received more withheld votes than affirmative votes.
- Confirm the high number of abstentions (1,967,329) on the executive compensation advisory vote relative to the "For" votes (686,535).
- Review the full proxy statement for context on the director nominees and the rationale behind the voting patterns.